PDE Inhibitors News and Research

RSS
FDA approved PDE4 inhibitor roflumilast for atopic dermatitis

FDA approved PDE4 inhibitor roflumilast for atopic dermatitis

Charting the future of IBD treatment: From immune modulators to microRNA therapies

Charting the future of IBD treatment: From immune modulators to microRNA therapies

Novel and emerging therapies offer new hope for patients with inflammatory bowel disease

Novel and emerging therapies offer new hope for patients with inflammatory bowel disease

UCI discovery may lead to mitigation of side effects caused by erectile dysfunction drugs

UCI discovery may lead to mitigation of side effects caused by erectile dysfunction drugs

Drug in clinical trials for Parkinson's disease offers hope for treating heart failure

Drug in clinical trials for Parkinson's disease offers hope for treating heart failure

biocrea and Pfizer jointly presented details on novel PDE10 inhibitors

biocrea and Pfizer jointly presented details on novel PDE10 inhibitors

New insight into Duchenne muscular dystrophy

New insight into Duchenne muscular dystrophy

CombinatoRx reports $41.3M total revenue for first-quarter 2010

CombinatoRx reports $41.3M total revenue for first-quarter 2010

Synergistic interactions of A2A Agonist and PDE Inhibitors as adjunctive therapy to GC for treating MM

Synergistic interactions of A2A Agonist and PDE Inhibitors as adjunctive therapy to GC for treating MM

Discovery of molecular pathway in brain may reverse cognitive impact of sleep deprivation

Discovery of molecular pathway in brain may reverse cognitive impact of sleep deprivation

Smelling for first time results from knowing abnormalities in congenital loss of smell

Smelling for first time results from knowing abnormalities in congenital loss of smell

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.